Sonavex, Inc., a privately held medical device company focused on improving surgical patient outcomes with point-of-care imaging technologies, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its EchoMark and EchoMark LP soft tissue markers.
{iframe}http://www.sonavex.com/sonavex-receives-fda-510k-clearance-for-echomark–echomark-lp-tissue-markers.html{/iframe}